开云app官网登录入口网页版-官方正版

#RNA干扰#

10篇内容 | 1160人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211811, encodeId=25c1221181123, content=<a href='/topic/show?id=74672339e92' target=_blank style='color:#2F92EE;'>#乙型肝炎病毒#</a> <a href='/topic/show?id=370215539f6' target=_blank style='color:#2F92EE;'>#RNAi疗法#</a> <a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=STTT：复旦大学袁正宏/占昌友等合作开发治疗乙型肝炎病毒感染的潜在新策略, objectType=article, longId=831570, objectId=d8e48315e0de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719324459455_5579292.jpg, objectUrl=/article/show_article.do?id=d8e48315e0de, replyNumber=0, likeNumber=85, createdTime=2024-06-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d8e48315e0de, moduleTitle=STTT：复旦大学袁正宏/占昌友等合作开发治疗乙型肝炎病毒感染的潜在新策略, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d8e48315e0de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1634907, encodeId=1395163490ee6, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性, objectType=article, longId=724367, objectId=a951e2436726, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a951e2436726, replyNumber=0, likeNumber=73, createdTime=2022-07-17, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a951e2436726, moduleTitle=Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a951e2436726)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634905, encodeId=b8d41634905c9, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=10亿美元收购RNA干扰疗法ARO-AAT，治疗遗传性肝病, objectType=article, longId=201997, objectId=0f3820199ee5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f3820199ee5, replyNumber=0, likeNumber=67, createdTime=2021-08-09, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3820199ee5, moduleTitle=10亿美元收购RNA干扰疗法ARO-AAT，治疗遗传性肝病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0f3820199ee5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634906, encodeId=053f163490629, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Nat Commun：AGO2突变影响RNA干扰和人类神经发育, objectType=article, longId=203832, objectId=5f38203832ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f38203832ff, replyNumber=0, likeNumber=70, createdTime=2020-11-28, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f38203832ff, moduleTitle=Nat Commun：AGO2突变影响RNA干扰和人类神经发育, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5f38203832ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634904, encodeId=349f1634904c6, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Alnylam的RNA干扰药物Givlaari作为欧盟首例治疗急性肝卟啉症的药物，获得了CHMP的积极评价, objectType=article, longId=187288, objectId=72c718e28817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72c718e28817, replyNumber=0, likeNumber=65, createdTime=2020-02-15, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72c718e28817, moduleTitle=Alnylam的RNA干扰药物Givlaari作为欧盟首例治疗急性肝卟啉症的药物，获得了CHMP的积极评价, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=72c718e28817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634903, encodeId=90861634903e1, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Cell Res:RNA干扰被发现是人类神经早期发育的“保护伞”, objectType=article, longId=164826, objectId=e5e6164826e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e6164826e7, replyNumber=0, likeNumber=68, createdTime=2020-01-15, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e6164826e7, moduleTitle=Cell Res:RNA干扰被发现是人类神经早期发育的“保护伞”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e5e6164826e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634902, encodeId=9f4f16349029d, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据, objectType=article, longId=164220, objectId=392016422049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=392016422049, replyNumber=0, likeNumber=72, createdTime=2019-10-03, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=392016422049, moduleTitle=2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=392016422049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634900, encodeId=d39d163490080, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Acta Biomater：新型水凝胶递送RNA干扰分子可有效治疗骨缺损, objectType=article, longId=141374, objectId=aa1d1413e434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa1d1413e434, replyNumber=0, likeNumber=67, createdTime=2018-09-18, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa1d1413e434, moduleTitle=Acta Biomater：新型水凝胶递送RNA干扰分子可有效治疗骨缺损, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aa1d1413e434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634901, encodeId=20a71634901c1, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=NEJM：RNA干扰治疗遗传性转胸腺肽淀粉样变性, objectType=article, longId=142608, objectId=6a9414260871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a9414260871, replyNumber=0, likeNumber=64, createdTime=2019-01-02, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a9414260871, moduleTitle=NEJM：RNA干扰治疗遗传性转胸腺肽淀粉样变性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6a9414260871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634899, encodeId=59561634899f7, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=靶向RNA干扰疗法能有效减少卟啉症发作, objectType=article, longId=100480, objectId=f7fc1004806c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7fc1004806c, replyNumber=0, likeNumber=75, createdTime=2018-01-31, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7fc1004806c, moduleTitle=靶向RNA干扰疗法能有效减少卟啉症发作, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f7fc1004806c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634898, encodeId=6baa1634898bd, content=<a href='/topic/show?id=972a1555eed' target=_blank style='color:#2F92EE;'>#RNA干扰#</a>, objectTitle=Sci Rep：RNA干扰系统在哺乳动物细胞内具有抗病毒功能, objectType=article, longId=70363, objectId=ab43e0363e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab43e0363e3, replyNumber=0, likeNumber=74, createdTime=2017-05-24, rootId=0, userName=1194695146_61857354, userId=411a22326910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab43e0363e3, moduleTitle=Sci Rep：RNA干扰系统在哺乳动物细胞内具有抗病毒功能, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ab43e0363e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

RNA干扰

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#乙型肝炎病毒# #RNAi疗法# #RNA干扰#

STTT：复旦大学袁正宏/占昌友等合作开发治疗乙型肝炎病毒感染的潜在新策略

2024-06-26发表于上海

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Nature Biomedical Engineering: 用魔法打败魔法？利用RNA干扰降低CRISPR在肝脏中的脱靶性

2022-07-17

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

10亿美元收购RNA干扰疗法ARO-AAT，治疗遗传性肝病

2021-08-09

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Nat Commun：AGO2突变影响RNA干扰和人类神经发育

2020-11-28

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Alnylam的RNA干扰药物Givlaari作为欧盟首例治疗急性肝卟啉症的药物，获得了CHMP的积极评价

2020-02-15

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Cell Res:RNA干扰被发现是人类神经早期发育的“保护伞”

2020-01-15

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据

2019-10-03

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Acta Biomater：新型水凝胶递送RNA干扰分子可有效治疗骨缺损

2018-09-18

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

NEJM：RNA干扰治疗遗传性转胸腺肽淀粉样变性

2019-01-02

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

靶向RNA干扰疗法能有效减少卟啉症发作

2018-01-31

1194695146_61857354 (审核中...)

前往app查看评论内容

#RNA干扰#

Sci Rep：RNA干扰系统在哺乳动物细胞内具有抗病毒功能

2017-05-24

科室
- - 订阅+
  - 更多科室
工具
服务